Find Federal Grants
Office for Victims of Crime · O-OVC-2023-171670
Administration for Children and Families - OPRE · HHS-2023-ACF-OPRE-YR-0153
Administration for Children and Families - OPRE · HHS-2023-ACF-OPRE-YE-0154
Entry-Level Modules (ELM) for Training the Genomics Research Workforce (R25-Clinical Trial Not Allowed)
National Institutes of Health · PAR-23-123
Administration for Community Living · HHS-2023-ACL-AOA-LRLI-0014
Lifespan Respite Care Program: Grants to New States and States Re-Establishing Their Core Respite Infrastructures
Administration for Community Living · HHS-2023-ACL-AOA-LRLR-0017
BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
National Institutes of Health · RFA-NS-24-005
BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
National Institutes of Health · RFA-NS-24-004
Administration for Children and Families - OHS · HHS-2023-ACF-OHS-CH-R8-0079
Administration for Children and Families - OHS · HHS-2023-ACF-OHS-CH-R2-0081
Administration for Children and Families - OHS · HHS-2023-ACF-OHS-CH-R6-0080
Office for Victims of Crime · O-OVC-2023-171660
Population Dynamics Centers Research Infrastructure Program FY 2024 (P2C Clinical Trial Not Allowed)
National Institutes of Health · RFA-HD-24-008
Office for Victims of Crime · O-OVC-2023-171656
Understanding Chronic Conditions Understudied Among Women (R21 Clinical Trial Optional)
National Institutes of Health · RFA-OD-23-013
Understanding Chronic Conditions Understudied Among Women (R01 Clinical Trial Optional)
National Institutes of Health · RFA-OD-23-014
Employer Engagement Program
Administration for Children and Families - ORR · HHS-2023-ACF-ORR-ZN-0018
The Eldercare Locator
Administration for Community Living · HHS-2023-ACL-AOA-EEIR-0013
Administration for Children and Families - ACYF/CB · HHS-2023-ACF-ACYF-CT-0010
Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
National Institutes of Health · PAR-23-131